IRadimed Corporation
IRMD
$96.15
-$0.11-0.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.88% | 13.73% | 10.80% | 10.39% | 11.87% |
| Total Depreciation and Amortization | 42.54% | 18.39% | -3.18% | -2.82% | 6.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 209.88% | 59.01% | 76.20% | -15.50% | 28.55% |
| Change in Net Operating Assets | -215.87% | -108.42% | 151.06% | 145.61% | 163.45% |
| Cash from Operations | -2.64% | 6.20% | 71.48% | 104.95% | 90.30% |
| Capital Expenditure | 3.00% | -78.55% | -476.12% | -769.21% | -7.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.22% | -23.90% | -52.23% | -34.20% | -43.31% |
| Cash from Investing | 4.49% | -73.03% | -389.63% | -535.36% | -10.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -85.12% | -85.12% | -83.59% | -83.59% |
| Repurchase of Common Stock | -272.31% | -35.77% | -30.65% | -18.56% | -12.70% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.97% | 28.78% | 17.73% | 1.42% | -3.43% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.77% | 24.92% | 13.82% | -1.78% | -4.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.48% | -3.43% | 64.46% | 121.51% | 130.15% |